NPI: 1801999479 · LEAKESVILLE, MS 39451 · Federally Qualified Health Center (FQHC) · NPI assigned 09/07/2006
Authorized official GREER, ANGELIQUE controls 20+ related entities in our dataset. Read more
| Authorized Official | GREER, ANGELIQUE (EXECUTIVE DIRECTOR) |
| NPI Enumeration Date | 09/07/2006 |
Other providers sharing the same authorized official: GREER, ANGELIQUE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 436 | $25K |
| 2019 | 1,478 | $53K |
| 2020 | 1,094 | $53K |
| 2021 | 2,421 | $114K |
| 2022 | 2,880 | $112K |
| 2023 | 3,501 | $127K |
| 2024 | 2,703 | $88K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,695 | 3,133 | $336K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,361 | 2,049 | $180K |
| 92551 | 597 | 538 | $13K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 63 | 57 | $6K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 357 | 355 | $4K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 565 | 469 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 55 | 55 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,053 | 914 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 843 | 728 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 506 | 446 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,011 | 850 | $2K |
| 87428 | 292 | 259 | $2K | |
| 87807 | 256 | 186 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 14 | 13 | $1K |
| 36415 | Collection of venous blood by venipuncture | 180 | 148 | $1K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 16 | 12 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 393 | 346 | $1K |
| 99173 | 723 | 640 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 27 | 14 | $662.76 |
| 81000 | 84 | 69 | $354.05 | |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 195 | 166 | $145.13 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 430 | 373 | $114.14 |
| 81003 | 26 | 26 | $20.88 | |
| 90686 | 104 | 96 | $0.00 | |
| 3008F | 151 | 128 | $0.00 | |
| 90651 | 23 | 15 | $0.00 | |
| 1126F | 75 | 71 | $0.00 | |
| 85018 | 54 | 52 | $0.00 | |
| 1125F | 17 | 12 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 14 | 13 | $0.00 |
| 3074F | 12 | 12 | $0.00 | |
| 86308 | 18 | 16 | $0.00 | |
| 1159F | 242 | 224 | $0.00 | |
| 90633 | 25 | 17 | $0.00 | |
| 90734 | 24 | 15 | $0.00 | |
| 83655 | 12 | 12 | $0.00 |